Boothbay Fund Management’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.3K Buy
24,363
+8,121
+50% +$11.8K ﹤0.01% 1177
2025
Q1
$22.4K Buy
+16,242
New +$22.4K ﹤0.01% 1156
2024
Q1
Sell
-13,293
Closed -$77.5K 1728
2023
Q4
$77.5K Buy
+13,293
New +$77.5K ﹤0.01% 1295